Table 3. The characteristics of 24 chemotherapeutic drugs.
| Drug | Target | Effects on autophagy | References (PMID) |
|---|---|---|---|
| Veliparib (ABT-888) | PARP1 and PARP2 inhibitor | Yes | 25975349 |
| Rucaparib (AG-014699) | PARP inhibitor | Yes | 31714594 |
| Axitinib | VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-β, and c-KIT | No report | NA |
| Saracatinib (AZD0530) | Src inhibitor | Yes | 32686156 |
| Selumetinib (AZD6244) | MEK inhibitor | Yes | 27448918 |
| AZD7762 | Chk1 and Chk2 inhibitor | No report | NA |
| AZD8055 | mTOR inhibitor | Yes | 31598395 |
| Afatinib (BIBW2992) | EGFR/ErbB inhibitor | Yes | 28676644 |
| BMS-754807 | IGF-1R/InsR | No report | NA |
| BX-795 | PDK1 and TBK1 inhibitor | Yes | 26607461 |
| Erlotinib | EGFR inhibitor | Yes | 32190291 |
| Pictilisib (GDC-0941) | PI3K inhibitor | Yes | 33048163 |
| Gefitinib | EGFR inhibitor | Yes | 33315519 |
| Imatinib | Tyrosine kinase inhibitor | Yes | 33066449 |
| JNJ-26854165 (Serdemetan) | HDM2 inhibitor | No report | NA |
| KU-55933 | ATM Kinase Inhibitor | Yes | 29921885 |
| Mitomycin C | DNA synthesis inhibitor | Yes | 29669822 |
| NU7441 | DNA-PK inhibitor | No report | NA |
| Linsitinib (OSI-906) | IGF-1R inhibitor | No report | NA |
| Parthenolide | NF-κB inhibitor | Yes | 31322140 |
| Pazopanib | VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit, and c-Fms/CSF1R inhibitor | Yes | 23887605 |
| Mirdametinib (PD0325901) | MEK inhibitor | Yes | 32268164 |
| PHA-665752 | c-Met inhibitor | No report | NA |
| Roscovitine (Seliciclib) | CDK inhibitor | Yes | 30899038 |
NA, not available.